COVID-19_YHLO

YHLO

YHLO

Language

Reproductive Health

Home page

2024/06/05

JTM-Inactivated COVID-19 vaccines durability of CovaxinBBV152 induced immunity against variants of concern

2024/06/05

JAMA-Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants With

2024/06/05

JH-Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients

2024/06/05

PNAS-High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19

2024/06/05

LID-SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India a prospective, active surveillance study

2024/06/05

NC-Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19

2024/06/05

Allergy-Antibody dynamics to SARS-CoV-2 in Asymptomatic and Mild COVID-19 patients

< 1 2 3 4 >

YHLO

Home
Products
- CLIA
  - Analyzers
  - Reagents
- Chemistry
- TLA
- LIA
- ESR
Pubilcations
- Autoimmunity
- Reproductive Health
- Diabetes
- Liver Disease
- Infection
- COVID-19
- ESR
- Others
News
- YHLO News
- Marketing Activities
About YHLO
Contact us
- Career
- Service

Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China

Tel: +86 755 26601910

Email: marketing@szyhlo.com

youtube

instagram

wechat

wechat

Copyright© 2024 Shenzhen YHLO Biotech Co., Ltd.

Powered by 300.cn | SEO | Business License

8

Email

marketing@szyhlo.com

9

Tel

+86 755 26601910